The U.S. Anxiety Access Report
A national overview of who reaches anxiety treatment in the United States and where access falls short. Built on NIMH, CDC, and peer-reviewed sources.
The Evidence. Understood.
AnxietyResearch.org reports on anxiety research, public-health data, and treatment access in the United States. The aim is to make studies and surveys readable. The site is editorial. It isn't medical advice.
Original briefs built from public datasets and peer-reviewed sources.
New state access reports
A national overview of who reaches anxiety treatment in the United States and where access falls short. Built on NIMH, CDC, and peer-reviewed sources.
Wait times for new outpatient psychiatric appointments often stretch beyond four weeks. Delays are longer in rural areas and for in-network providers.
Mental health workforce density and insurance acceptance vary dramatically across the 50 states and DC. Rural states often sit far below national averages.
Snapshot of the most-cited figures, updated as sources release new data.
The percentages cited above come from the National Comorbidity Survey Replication, conducted in 2001 to 2003 and published in 2005. NCS-R remains the canonical U.S. anchor for past-year and lifetime anxiety disorder rates because no later U.S. survey has replicated its full diagnostic interview. More recent surveys, such as the CDC Household Pulse Survey and the SAMHSA National Survey on Drug Use and Health, measure recent symptoms or self-reported diagnoses using different instruments and produce different anchor numbers. NCS-R figures should be read as the best available disorder-level estimate, with the caveat that the data aren't current-year.
Plain-English reviews of what current research does and does not show.
Cognitive behavioral therapy shows moderate to large effects across generalized anxiety, social anxiety, panic, and specific phobias in meta-analyses.
SSRIs and SNRIs produce small to moderate effect sizes versus placebo across most adult anxiety disorders and are first-line pharmacotherapy in major guidelines.
Exposure-based therapy produces large effect sizes for specific phobias and panic disorder. Inhibitory learning frameworks now guide protocol design.
How to read studies, weigh evidence, and avoid common misreadings of mental-health research.
Why pooled data sits at the top of the evidence hierarchy, and how it can be flawed.
The difference between observational associations and causal claims in mental health research.
A guide to evaluating press releases, relative risk, and observational claims.
Evidence syntheses on this site describe the clinical trials, systematic reviews, and guidelines that inform standard of care. They cover psychotherapeutic and pharmacological interventions. We track the latest evidence on efficacy, remission rates, and clinical outcomes.
All reports and summaries draw from peer-reviewed literature, clinical guidelines, and primary public health datasets. We prioritize systematic reviews and meta-analyses over single studies to ensure conclusions reflect the broader scientific consensus.
Every page undergoes editorial review by a board-certified psychiatrist for clinical accuracy before publication. Content is updated as major governing bodies or datasets release new findings.
The Shrink Network is an independent mental health knowledge ecosystem built around one idea: mental health is too important to squeeze into one website. Each site has one job. Together, they help people understand, apply, and access care. No matter where you enter the network, we help you find the next step that makes sense. Your mind. Understood.
AnxietyResearch.org is the evidence and research-translation layer. Honest summaries of what the peer-reviewed research and public datasets actually show about anxiety, panic, treatment, and access. When the next question is practical, foundational, medication-specific, or clinical, we route to the network property built for that job. See the About page for the full network map.
The anxiety-specific patient-education layer. Plain-language guidance on symptoms, panic, overthinking, work and relationships, plus state-by-state resource directories.
The depression-specific patient-education layer. Useful when a reader is researching anxiety alongside co-occurring depressive symptoms. See the report on anxiety and depression overlap.
For anxiety treatment, not just research, see shrinkMD, our clinical affiliate. Independent multistate telepsychiatry practice founded by the site's medical editor; that affiliation is disclosed on every page that links here, and this site takes no fees or referral revenue from the practice.
About the network
Mental health isn't one thing.
Anxiety research is its own subject.
It has its own evidence base, its own methodological debates, and its own gap between what the studies show and what reaches a clinic.
A site that tries to be about every mental health topic ends up too thin on the studies the questions actually live inside.
AnxietyResearch is the evidence layer of The Shrink Network. It translates anxiety research, statistics, and findings into clear language.
The Shrink Network is an independent mental health knowledge ecosystem built around one idea: mental health is too important to squeeze into one website. Each site has one job. Together, they help people understand, apply, and access care. No matter where you enter the network, we help you find the next step that makes sense.
Your mind. Understood.

A direct examination of cognitive distortions and anxiety patterns.
Exercises for identifying and challenging anxious thoughts.
Frameworks for interrupting panic and managing chronic overthinking.
Call or text 988 for free, confidential support available 24/7.
Text HOME to 741741 for 24/7 crisis support via text.
Call 988 and press 1, or text 838255.
Call 866-488-7386 or text START to 678-678.